Intervention
Mesenchymal Stem Cells
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 4 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
4 shownMesenchymal Stem Cells Infusion in Patients With Autoimmune DiseasesNCT06888973 · 2025-02-01
ENROLLING_BY_INVITATIONPhase IIa Randomized Placebo Controlled Trial: Mesenchymal Stem Cells as a Disease-modifying Therapy for Idiopathic Parkinson's DiseaseNCT04506073 · 2020-11-09
COMPLETEDMesenchymal Stem Cells in the Treatment of Subjects With Advance Chronic Obstructive Pulmonary Disease (COPD)NCT04047810 · 2020-01-06
COMPLETEDSafety and Efficacy of Intravenous Autologous Mesenchymal Stem Cells for MS: a Phase 2 Proof of Concept StudyNCT02239393 · 2015-06-01
COMPLETEDCommon conditions
Leading sponsors
Trial status mix
COMPLETED3
ENROLLING_BY_INVITATION1
Phase mix
PHASE23
PHASE12
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.